Identification of phoslactomycin E as a metabolite inducing hyphal morphological abnormalities in Aspergillus fumigatus IFO 5840

17Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

In our survey for antifungal compounds, a fermentation broth of Streptomyces sp. HA81-2 was found to inhibit the in vitro growth of Aspergillus fumigatus IFO 5840 accompanied by hyphal morphological abnormalities. One of the isolated antibiotics was identified as phoslactomycin E based on LC-MS and NMR spectral data. In a preliminary assay using the membrane fractions of A. fumigatus, phoslactomycin E was found to inhibit the activity of 1,3-β glucan synthase. © Japan Antibiotics Research Association.

Cite

CITATION STYLE

APA

Mizuhara, N., Usuki, Y., Ogita, M., Fujita, K. I., Kuroda, M., Doe, M., … Tanaka, T. (2007). Identification of phoslactomycin E as a metabolite inducing hyphal morphological abnormalities in Aspergillus fumigatus IFO 5840. Journal of Antibiotics, 60(12), 762–765. https://doi.org/10.1038/ja.2007.101

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free